The Type III secretion system of Gram-negative bacteria: a potential therapeutic target?

By Müller Simone   Feldman Mario F   Cornelis Guy R  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 327-339

Informa Healthcare

Access to resources Recommend Favorite

Isoprenoid Metabolism as a Therapeutic Target in Gram-Negative Pathogens

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 18, 2010-12 ,pp. : 1858-1871

Bentham Science Publishers

Access to resources Recommend Favorite

The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 3, 2010-09 ,pp. : 224-234

Bentham Science Publishers

Access to resources Recommend Favorite

Dermatan Sulfate as a Potential Therapeutic Agent

By Linhardt R.J.   Hileman R.E.  

General Pharmacology, Vol. 26, Iss. 3, 1995-05 ,pp. : 443-451

Elsevier

Access to resources Recommend Favorite

Evidence for tumor necrosis factor as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis

By Campanile F.   Giampietri A.   Grohmann U.   Belladonna M.L.   Fioretti M.C.   Puccetti P.  

European Journal of Pharmacology, Vol. 307, Iss. 2, 1996-06 ,pp. : 191-199

Elsevier

Access to resources Recommend Favorite